114 related articles for article (PubMed ID: 24064537)
1. Pancreastatin is an endogenous peptide that regulates glucose homeostasis.
Valicherla GR; Hossain Z; Mahata SK; Gayen JR
Physiol Genomics; 2013 Nov; 45(22):1060-71. PubMed ID: 24064537
[TBL] [Abstract][Full Text] [Related]
2. A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis.
Gayen JR; Saberi M; Schenk S; Biswas N; Vaingankar SM; Cheung WW; Najjar SM; O'Connor DT; Bandyopadhyay G; Mahata SK
J Biol Chem; 2009 Oct; 284(42):28498-509. PubMed ID: 19706599
[TBL] [Abstract][Full Text] [Related]
3. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
Díaz-Troya S; Najib S; Sánchez-Margalet V
Regul Pept; 2005 Feb; 125(1-3):41-6. PubMed ID: 15582712
[TBL] [Abstract][Full Text] [Related]
4. Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes.
González-Yanes C; Sánchez-Margalet V
Biochem Biophys Res Commun; 2001 Nov; 289(1):282-7. PubMed ID: 11708813
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin.
Sánchez-Margalet V; González-Yanes C; Najib S; Santos-Alvarez J
Regul Pept; 2010 Apr; 161(1-3):8-14. PubMed ID: 20184923
[TBL] [Abstract][Full Text] [Related]
6. Pancreastatin inhibits insulin action in rat adipocytes.
Sánchez-Margalet V; González-Yanes C
Am J Physiol; 1998 Dec; 275(6):E1055-60. PubMed ID: 9843749
[TBL] [Abstract][Full Text] [Related]
7. Naturally occurring variants of the dysglycemic peptide pancreastatin: differential potencies for multiple cellular functions and structure-function correlation.
Allu PK; Chirasani VR; Ghosh D; Mani A; Bera AK; Maji SK; Senapati S; Mullasari AS; Mahapatra NR
J Biol Chem; 2014 Feb; 289(7):4455-69. PubMed ID: 24338022
[TBL] [Abstract][Full Text] [Related]
8. Pancreastatin, a chromogranin A-derived peptide, inhibits leptin and enhances UCP-2 expression in isolated rat adipocytes.
González-Yanes C; Sánchez-Margalet V
Cell Mol Life Sci; 2003 Dec; 60(12):2749-56. PubMed ID: 14685697
[TBL] [Abstract][Full Text] [Related]
9. Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism.
O'Connor DT; Cadman PE; Smiley C; Salem RM; Rao F; Smith J; Funk SD; Mahata SK; Mahata M; Wen G; Taupenot L; Gonzalez-Yanes C; Harper KL; Henry RR; Sanchez-Margalet V
J Clin Endocrinol Metab; 2005 Sep; 90(9):5414-25. PubMed ID: 15956083
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel target for the dysglycemic chromogranin A fragment pancreastatin: interaction with the chaperone GRP78 to influence metabolism.
Biswas N; Friese RS; Gayen JR; Bandyopadhyay G; Mahata SK; O'Connor DT
PLoS One; 2014; 9(1):e84132. PubMed ID: 24465394
[TBL] [Abstract][Full Text] [Related]
11. Characterization of pancreastatin receptors and signaling in adipocyte membranes.
González-Yanes C; Santos-Alvarez J; Sánchez-Margalet V
Biochim Biophys Acta; 1999 Aug; 1451(1):153-62. PubMed ID: 10446397
[TBL] [Abstract][Full Text] [Related]
12. Pancreastatin, a chromogranin A-derived peptide, activates Galpha(16) and phospholipase C-beta(2) by interacting with specific receptors in rat heart membranes.
González-Yanes C; Santos-Alvarez J; Sánchez-Margalet V
Cell Signal; 2001 Jan; 13(1):43-9. PubMed ID: 11257446
[TBL] [Abstract][Full Text] [Related]
13. Discovery of pancreastatin inhibitor PSTi8 for the treatment of insulin resistance and diabetes: studies in rodent models of diabetes mellitus.
Hossain Z; Valicherla GR; Gupta AP; Syed AA; Riyazuddin M; Chandra S; Siddiqi MI; Gayen JR
Sci Rep; 2018 Jun; 8(1):8715. PubMed ID: 29880906
[TBL] [Abstract][Full Text] [Related]
14. Reprint of: Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin.
Sánchez-Margalet V; González-Yanes C; Najib S; Santos-Álvarez J
Regul Pept; 2010 Nov; 165(1):71-7. PubMed ID: 20934461
[TBL] [Abstract][Full Text] [Related]
15. The immunomodulatory functions of chromogranin A-derived peptide pancreastatin.
Ioannidis M; Mahata SK; van den Bogaart G
Peptides; 2022 Dec; 158():170893. PubMed ID: 36244579
[TBL] [Abstract][Full Text] [Related]
16. Pancreastatin receptor is coupled to a guanosine triphosphate-binding protein of the G(q/11)alpha family in rat liver membranes.
Santos-Alvarez J; González-Yanes C; Sánchez-Margalet V
Hepatology; 1998 Feb; 27(2):608-14. PubMed ID: 9462664
[TBL] [Abstract][Full Text] [Related]
17. Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance.
Bandyopadhyay GK; Lu M; Avolio E; Siddiqui JA; Gayen JR; Wollam J; Vu CU; Chi NW; O'Connor DT; Mahata SK
Diabetes; 2015 Jan; 64(1):104-16. PubMed ID: 25048197
[TBL] [Abstract][Full Text] [Related]
18. Pancreastatin, a chromogranin A-derived peptide, inhibits DNA and protein synthesis by producing nitric oxide in HTC rat hepatoma cells.
Sánchez-Margalet V; González-Yanes C; Najib S
J Hepatol; 2001 Jul; 35(1):80-5. PubMed ID: 11495046
[TBL] [Abstract][Full Text] [Related]
19. Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway.
Gupta AP; Syed AA; Garg R; Goand UK; Singh P; Riyazuddin M; Valicherla GR; Husain A; Gayen JR
Eur J Pharmacol; 2019 Dec; 864():172723. PubMed ID: 31586632
[TBL] [Abstract][Full Text] [Related]
20. Pancreastatin: characterization of biological activity.
Zhang T; Mochizuki T; Kogire M; Ishizuka J; Yanaihara N; Thompson JC; Greeley GH
Biochem Biophys Res Commun; 1990 Dec; 173(3):1157-60. PubMed ID: 2268319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
